S100 can be used as a tumor marker in canine mammary tumors

Journal Title: National Journal of Physiology, Pharmacy and Pharmacology - Year 2018, Vol 8, Issue 7

Abstract

Background: S100 protein has been localized in different normal and tumorous tissues. Furthermore, its use in tumor localization and identification has already been established. Aims and Objectives: The aim of this study is to determine the localization and distribution of S100 immunoreactive cells in different canine mammary tumors (CMTs). Materials and Methods: The localization of S100 protein was demonstrated in sections of ten different classifications of CMTs and one normal lactating mammary gland by immunohistochemistry. 10 CMT samples were obtained from tumor resections in different veterinary clinics and hospital in Metro Manila, Philippines, and one normal lactating mammary gland was obtained from an anatomy cadaver for comparison. Results: S100 was observed to be positive in the endothelial cells of blood vessels in all the samples which make it suitable as a marker for CMT. Other cells that have been observed to be moderate-to-high immunoreactivity are spindle-shaped cells, chondrocytes and stromal cells which may serve as tumor markers. A positive immunoreactivity on some neuroendocrine cells and epithelial cells was also observed in neuroendocrine differentiated carcinoma. Conclusion: Based on the results in 10 CMT, this study suggests that S100 immunohistochemistry can be used as a marker to confirm CMT.

Authors and Affiliations

Khristine Kaith S Lloren, Rodel Jonathan S Vitor II

Keywords

Related Articles

Anthropometric differences and gender variations in brainstem auditory evoked responses - A cross-sectional study in North Indian population

Background: Gender is a known physiological variable reported to have influences on brainstem auditory evoked potential (BAEP) latencies irrespective of age. Anatomical differences have been suggested for such variations...

A study of heart rate variability among non-diabetic offspring of type 2 diabetic parents

Background: Type 2 diabetes mellitus is an inheritable condition that runs in families as a disorder of impaired glycemic control and its complications. Among the complications of diabetes, autonomic neuropathy contribut...

Amphotericin B abolishes the cytotoxic effect of Toll-like receptor 9 agonist CpG Oligonucleotides in breast cancer cell line MCF-7

Background: Toll-like receptors (TLRs) are key sensors of microbial components and triggers signals responsible for the activation of innate immune responses. Unmethylated cytosine-guanosine oligodeoxynucleotides called...

Effect of Pterocarpus marsupium in animal model of high carbohydrate diet-induced metabolic syndrome

Background: Metabolic syndrome (MS) is a group of interconnected disorder linked to obesity, insulin resistance hypertension, and dyslipidemia. It is a risk factor for the development of Type II diabetes and cardiovascul...

Condition of inflammation mediators and antioxidant protection system for endometriosis genitalis in women of reproductive age

Background: The paper presents the data on a condition and a role of inflammation mediators and the antioxidant protection system in blood plasma for endometriosis genitalis (EG) in women of reproductive age. The materia...

Download PDF file
  • EP ID EP491237
  • DOI 10.5455/njppp.2018.8.0206024022018
  • Views 90
  • Downloads 0

How To Cite

Khristine Kaith S Lloren, Rodel Jonathan S Vitor II (2018). S100 can be used as a tumor marker in canine mammary tumors. National Journal of Physiology, Pharmacy and Pharmacology, 8(7), 928-939. https://europub.co.uk./articles/-A-491237